DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
INDIGO CARMINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INDIGO CARMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODIDE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
IODIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PATROL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
PATROL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LIDOCAINE; TETRACAINE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
LIDOCAINE; TETRACAINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRISEOFULVIN, MICROCRYSTALLINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
GRISEOFULVIN, MICROCRYSTALLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYANOCOBALAMIN CO 58
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYANOCOBALAMIN CO 58
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C63H89CoN14O14P
Molecular Weight:
1355.4
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
KAD-1229
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
KAD-1229
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDIUM IN-111 CHLORIDE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
INDIUM IN-111 CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEUKOTRIENE D4
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
LEUKOTRIENE D4
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBALT CHLORIDE CO-57; CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR
4
Combination
Approved
OTHER
N/A
Unknown
Unknown
COBALT CHLORIDE CO-57; CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; INTRINSIC FACTOR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHOSPHORIC ACID
4
Small molecule
Approved
Unknown
Unknown
Familial Hypophosphatemic Rickets
Unknown
PHOSPHORIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
E4GA8884NN
Molecule Type:
Small molecule
Molecular Formula:
H3O4P
Molecular Weight:
97.99
AlogP:
-0.93
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
0.0
Source:
SODIUM PERTECHNETATE TC 99M
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
SODIUM PERTECHNETATE TC 99M
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
NaO4Tc
Molecular Weight:
185.89
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FRESH FROZEN PLASMA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FRESH FROZEN PLASMA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIMETHINDENE MALEATE
4
Small molecule
Approved
Unknown
Unknown
Arrhythmias, Cardiac
Unknown
DIMETHINDENE MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
6LL60J9E0O
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O4
Molecular Weight:
408.5
AlogP:
4.15
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
DEQUALINIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DEQUALINIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
E7QC7V26B8
Molecule Type:
Small molecule
Molecular Formula:
C30H40N4+2
Molecular Weight:
456.68
AlogP:
6.17
PSA:
59.8
HBD:
2.0
HBA:
#RotB:
11.0
Source:
FAMOTIDINE; IBUPROFEN
4
Combination
Approved
MUSCULOSKELETAL
ORAL
Unknown
Unknown
FAMOTIDINE; IBUPROFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALGINATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ALGINATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE
4
Unknown
Approved
OTHER
ORAL
Unknown
Unknown
CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALCLOFENAC
4
Small molecule
Approved
Unknown
Unknown
Rheumatic Diseases
Cyclooxygenase-1 inhibitor
ALCLOFENAC
×
Maximum Phase:
4
First Approval:
None
UNII:
M9CP5H21N8
Molecule Type:
Small molecule
Molecular Formula:
C11H11ClO3
Molecular Weight:
226.66
AlogP:
2.53
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
APATINIB
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
APATINIB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATALUREN
4
Small molecule
Approved
Unknown
Unknown
Aniridia; Epilepsy; Hemophilia A; Hemophilia B; Cystic Fibrosis; Muscular Dystrophy, Duchenne
80S Ribosome modulator
ATALUREN
×
Maximum Phase:
4
First Approval:
None
UNII:
K16AME9I3V
Molecule Type:
Small molecule
Molecular Formula:
C15H9FN2O3
Molecular Weight:
284.25
AlogP:
3.24
PSA:
76.22
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TEICOPLANIN
4
Unknown
Approved
Unknown
Unknown
Cystic Fibrosis; Osteomyelitis; Infections; Skin Diseases; Bacterial Infections
Peptidoglycan disrupting agent
TEICOPLANIN
×
Maximum Phase:
4
First Approval:
None
UNII:
4U3D3YY81M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETOMENAPHTHONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ACETOMENAPHTHONE
×
Maximum Phase:
4
First Approval:
None
UNII:
DWG8UZD9HT
Molecule Type:
Small molecule
Molecular Formula:
C15H14O4
Molecular Weight:
258.27
AlogP:
3.0
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN [INJECTION], BIPHASIC
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN [INJECTION], BIPHASIC
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BEVACIZUMAB-BVZR
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BEVACIZUMAB-BVZR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOCOPHERSOLAN
4
Unknown
Approved
Unknown
Unknown
Malaria; Short Bowel Syndrome; Hypobetalipoproteinemias
Unknown
TOCOPHERSOLAN
×
Maximum Phase:
4
First Approval:
None
UNII:
O03S90U1F2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CRISANTASPASE
4
Enzyme
Unknown
Unknown
Unknown
Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Asparagine hydrolytic enzyme
CRISANTASPASE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TELMISARTAN; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
TELMISARTAN; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CORTICOTROPIN-ZINC HYDROXIDE
4
Protein
Approved
OTHER
INJECTION
Unknown
Unknown
CORTICOTROPIN-ZINC HYDROXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
IOXAGLATE MEGLUMINE; IOXAGLATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
286
287
288
289
290
291
292
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA